Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70,106 | 246,662 | 76,497 | 81,331 | 87,928 |
| Marketable Securities | 235,366 | 252,272 | 210,344 | 208,619 | 203,509 |
| Receivables | 28,208 | 25,506 | 24,624 | N/A | N/A |
| Inventories | 15,024 | 6,674 | 2,355 | N/A | N/A |
| TOTAL | $355,814 | $534,853 | $316,789 | $308,915 | $293,889 |
| Non-Current Assets | |||||
| PPE Net | 185 | 150 | 166 | 173 | 186 |
| Investments And Advances | 200,616 | 57,148 | 7,002 | 0 | 27,211 |
| Intangibles | 4,861 | 5,347 | 5,832 | 6,318 | 6,805 |
| Other Non-Current Assets | 2,354 | 2,397 | 2,517 | 2,686 | 2,881 |
| TOTAL | $208,016 | $65,042 | $15,517 | $9,177 | $37,083 |
| Total Assets | $563,830 | $599,895 | $332,306 | $318,092 | $330,972 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,435 | 8,145 | 6,216 | 5,483 | 8,882 |
| Accrued Expenses | 9,677 | 7,248 | 8,539 | 6,524 | 4,776 |
| Other current liabilities | 38,525 | 17,163 | 5,512 | 3,127 | 4,563 |
| TOTAL | $61,363 | $33,253 | $20,943 | $15,731 | $18,747 |
| Non-Current Liabilities | |||||
| Long Term Debt | 49,863 | 49,854 | 49,845 | 49,836 | 49,828 |
| Other Non-Current Liabilities | 2,489 | 21,983 | 21,378 | 20,264 | 17,284 |
| TOTAL | $52,352 | $71,837 | $71,223 | $70,100 | $67,112 |
| Total Liabilities | $113,715 | $105,090 | $92,166 | $85,831 | $85,859 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,624 | 53,710 | 53,145 | 50,394 | 45,857 |
| Common Shares | 52 | 54 | 50 | 49 | 46 |
| Retained earnings | -431,370 | -474,728 | -500,741 | -496,033 | -452,260 |
| Other shareholders' equity | 415 | 360 | 85 | 226 | 361 |
| TOTAL | $450,115 | $494,805 | $240,140 | $232,261 | $245,113 |
| Total Liabilities And Equity | $563,830 | $599,895 | $332,306 | $318,092 | $330,972 |